CELU
CelularityCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-03
Current thesis
Composite grade C from latest DB weights. Momentum 55.3 / Value 41.1
Posture
Mixed
Lead driver
Momentum
What changed
Next scheduled catalyst: earnings 2026-06-08.
What can break
Mixed signals. Wait for cleaner trend confirmation.
Momentum
55
Value
41
Sentiment
N/A
Setup hits (3d)
0 · Net Neutral
AI TargetsBase - · Bull - · Bear -
Earnings
2026-06-08
Data freshness
Prices
As of 2026-06-03
Fundamentals
As of 2026-06-02 • Vendor: Data Vendor v1
Scores
As of 2026-06-03 • Model: HYBRID_IC_RP
AI Memo
Unavailable: No memo yet
Investment thesisAs of 2026-06-03
Investment thesis
As of 2026-06-03
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Neutral
Target $6.00
Why
Momentum55 · Δ7d -
Value41 · Δ7d +0.0
SentimentN/A · Δ7d -
So what
Balanced signals (Net Neutral). Wait for confirmation before sizing up.
Lead driver: Momentum · See technicals
Momentum
55
52% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
41
48% active weight
Current posture
7d trendFlat
Δ7d
+0.0
Δ21d
+0.2
Sentiment
N/A
Coverage pending
No current score
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade C. Momentum 55.3 / Value 41.1
Fundamentals (TTM)As of 2026-06-02
Fundamentals (TTM)
As of 2026-06-02
Market Cap
$30.68M
Beta
0.79
Shares Out
28.48M
P/E (TTM) · Derived
-0.4
P/S (TTM)
0.88
P/FCF (TTM) · Derived
-3.19
Rev YoY
-43.2%
EPS YoY
-19.6%
Gross Margin
+50.6%
Op Margin
-141.0%
Net Debt
$41.55M
Current Ratio
0.16
As of 2026-06-03 • Updated nightlySource: Internal modelMethodology